Results 11 to 20 of about 47,605 (207)
Trends in Microbiology, 2022 Acinetobacter baumannii is a ubiquitous, Gram-negative, nonflagellated coccobacillus bacterium commonly isolated from the environment. In human medicine, this opportunistic pathogen is responsible for hospital- and community-acquired infections. Resistance to last-resort antibiotics, such as colistin, tigecycline, and carbapenems, earns this bacterium ...
Clémence Whiteway +3 more
openaire +4 more sources
Tackling Acinetobacter baumannii
Journal of Clinical Medicine, 2023 Globally, multidrug-resistant (MDR) bacteria represent a menace to public health [...]
Guido Granata +2 more
openaire +2 more sources
Subunit vaccines for Acinetobacter baumannii
Frontiers in Immunology, 2023 Acinetobacter baumannii is a gram-negative bacterium and a crucial opportunistic pathogen in hospitals. A. baumannii infection has become a challenging problem in clinical practice due to the increasing number of multidrug-resistant strains and their prevalence worldwide. Vaccines are effective tools to prevent and control A. baumannii infection.
Ning Yang +6 more
openaire +3 more sources
Glycosphingolipids Recognized by Acinetobacter baumannii [PDF]
Microorganisms, 2020 Acinetobacter baumannii is an opportunistic bacterial pathogen associated with hospital-acquired infections, including pneumonia, meningitis, bacteremia, urinary tract infection, and wound infections. Recognition of host cell surface carbohydrates plays a crucial role in adhesion and enables microbes to colonize different host niches.
Miralda Madar Johansson +6 more
openaire +3 more sources
Acinetobacter in veterinary medicine, with an emphasis on Acinetobacter baumannii [PDF]
Journal of Global Antimicrobial Resistance, 2019 Acinetobacter spp. are aerobic, rod-shaped, Gram-negative bacteria belonging to the Moraxellaceae family of the class Gammaproteobacteria and are considered ubiquitous organisms. Among them, Acinetobacter baumannii is the most clinically significant species with an extraordinary ability to accumulate antimicrobial resistance and to survive in the ...
J.H. van der Kolk +4 more
openaire +3 more sources
The intracellular life of Acinetobacter baumannii
Trends in Microbiology, 2023 Acinetobacter baumannii is a Gram-negative opportunistic bacterium responsible for nosocomial and community-acquired infections. This pathogen is globally disseminated and associated with high levels of antibiotic resistance, which makes it an important threat to human health. Recently, new evidence showed that several A. baumannii isolates can survive
Alexandra Maure +2 more
openaire +2 more sources
Antibiotics, 2022 Acinetobacter baumannii is a multidrug-resistant and invasive pathogen associated with the etiopathology of both an increasing number of nosocomial infections and is of relevance to poultry production systems.
Yan Zhang +14 more
doaj +1 more source
PLoS ONE, 2014 BackgroundFew clinical data are available on the relationship between genospecies and outcome of Acinetobacter bacteremia, and the results are inconsistent.
Kyung-Hwa Park +9 more
doaj +1 more source
Prevalensi Gen OXA-23 pada Isolat Klinis Bakter Acinetobacter baumanii di RSUP Dr. M. Djamil Padang
Jurnal Ilmu Kesehatan Indonesia, 2021 Acinetobacter baumannii is such a big challenge in this modern era because of their multi-drug resistance (MDR) through their resistance mechanism, namely the production of beta lactamase enzymes, one of them is oxacillinases.
Mhd. Alzaref +2 more
doaj +1 more source
Molecular Identification of Acinetobacter baumanii and Acinetobacter genomic species 13TU Using PCR
Zanco Journal of Pure and Applied Sciences, 2019 Acinetobacter baumannii is well known to be multi-drug resistant and associated with many infectins. Manual and automated identification systems, can not differentiate between both species A. baumannii and Acinetobacter genomic species 13TU.
Salah Tofik Jalal Balaky +4 more
doaj +1 more source